Józef Kapusta
Polish Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Józef Kapusta.
The FASEB Journal | 1999
Józef Kapusta; Anna Modelska; M. Figlerowicz; Tomasz Pniewski; M. Letellier; O. Lisowa; Vidadi Yusibov; Hilary Koprowski; A. Plucienniczak; Andrzej B. Legocki
The infectious hepatitis B virus represents 42 nm spherical double‐shelled particles. However, analysis of blood from hepatitis B virus carriers revealed the presence of smaller 22 nm particles consisting of a viral envelope surface protein. These particles are highly immunogenic and have been used in the design of hepatitis B virus vaccine produced in yeast. Upon expression in yeast, these proteins form virus‐like particles that are used for parenteral immunization. Therefore, the DNA fragment encoding hepatitis B virus surface antigen was introduced into Agrobacterium tumerifacience LBA4404 and used to obtain transgenic lupin (Lupinus luteus L.) and lettuce (Lactuca sativa L.) cv. Burpee Bibb expressing envelope surface protein. Mice that were fed the transgenic lupin tissue developed significant levels of hepatitis B virus‐specific antibodies. Human volunteers, fed with transgenic lettuce plants expressing hepatitis B virus surface antigen, developed specific serum‐IgG response to plant produced protein.—Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., Legocki, A. B. A plant‐derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796–1799 (1999)
Journal of Applied Genetics | 2011
Tomasz Pniewski; Józef Kapusta; Piotr Bociąg; Jacek Wojciechowicz; Anna Kostrzak; Michał Gdula; Olga Fedorowicz-Strońska; Piotr Wójcik; Halina Otta; Sławomir Samardakiewicz; Bogdan Wolko; Andrzej Płucienniczak
Efficient immunization against hepatitis B virus (HBV) and other pathogens with plant-based oral vaccines requires appropriate plant expressors and the optimization of vaccine compositions and administration protocols. Previous immunization studies were mainly based on a combination of the injection of a small surface antigen of HBV (S-HBsAg) and the feeding with raw tissue containing the antigen, supplemented with an adjuvant, and coming from plants conferring resistance to kanamycin. The objective of this study was to develop a prototype oral vaccine formula suitable for human immunization. Herbicide-resistant lettuce was engineered, stably expressing through progeny generation micrograms of S-HBsAg per g of fresh weight and formed into virus-like particles (VLPs). Lyophilized tissue containing a relatively low, 100-ng VLP-assembled antigen dose, administered only orally to mice with a long, 60-day interval between prime and boost immunizations and without exogenous adjuvant, elicited mucosal and systemic humoral anti-HBs responses at the nominally protective level. Lyophilized tissue was converted into tablets, which preserved S-HBsAg content for at least one year of room temperature storage. The results of the study provide indications on immunization methodology using a durable, efficacious, and convenient plant-derived prototype oral vaccine against hepatitis B.
Advances in Experimental Medicine and Biology | 2001
Józef Kapusta; Anna Modelska; Tomasz Pniewski; Magdalena Figlerowicz; Kacper Jankowski; Olesia Lisowa; Andrzej Płucienniczak; Hilary Koprowski; Andrzej B. Legocki
A number of reports for the past few years have shown that higher plants can be important and useful tools for production and delivery of viral antigens. Oral route represents one of the most efficient and safe ways for administration of therapeutic proteins [1]. Among protein antigens expressed in transgenic plants is hepatitis B surface antigen as reported by several laboratories.
Plant Cell Reports | 2012
Tomasz Pniewski; Józef Kapusta; Piotr Bociąg; Anna Kostrzak; Olga Fedorowicz-Strońska; Marcin Czyż; Michał Gdula; Paweł Krajewski; Bogdan Wolko; Andrzej Płucienniczak
Current immunisation programmes against hepatitis B virus (HBV) increasingly often involve novel tri-component vaccines containing—together with the small (S-HBsAg)—also medium and large surface antigens of HBV (M- and L-HBsAg). Plants producing all HBsAg proteins can be a source of components for a potential oral ‘triple’ anti-HBV vaccine. The objective of the presented research was to study the potential of M/L-HBsAg expression in leaf tissue and conditions of its processing for a prototype oral vaccine. Tobacco and lettuce carrying M- or L-HBsAg genes and resistant to the herbicide glufosinate were engineered and integration of the transgenes was verified by PCR and Southern hybridizations. M- and L-HBsAg expression was confirmed by Western blot and assayed by ELISA at the level of micrograms per g of fresh weight. The antigens displayed a common S domain and characteristic domains preS2 and preS1 and were assembled into virus-like particles (VLPs). Leaf tissues containing M- and L-HBsAg were lyophilised to produce a starting material of an orally administered vaccine formula. The antigens were distinctly sensitive to freeze-drying conditions and storage temperature, in the aspect of stability of S and preS domains and formation of multimeric particles. Efficiency of lyophilisation and storage depended also on the initial antigen content in plant tissue, yet M-HBsAg appeared to be approximately 1.5–2 times more stable than L-HBsAg. The results of the study provide indications concerning the preparation of two other constituents, next to S-HBsAg, for a plant-derived prototype oral tri-component vaccine against hepatitis B.
Journal of Applied Genetics | 2006
Tomasz Pniewski; Józef Kapusta; Andrzej Płucienniczak
The idea of an oral vaccine administered as a portion of plant tissue requires a high level of antigen production. An improved protocol for the induction of transgenic yellow lupin calli or tumours, reaching 44% of transformation rate, is presented here. It has been developed by using thenptII marker gene and theuidA reporter gene as well as variousAgrobacterium strains and plant explants. This method of seedling and hypocotyl transformation was applied to raise calli or tumours producing a small surface antigen of Hepatitis B Virus (S-HBsAg). Lupin tissue lines were long-term cultured on selection media maintaining the growth rate and high expression level of the native form of S-HBs, up to 6 μg per g of fresh tissue.
Plant Cell Reports | 2016
Olga Fedorowicz-Strońska; Józef Kapusta; Marcin Czyż; Małgorzata Kaczmarek; Tomasz Pniewski
Key messageIntramuscularly delivered plant-derived M-HBsAg was compared to S-HBsAg, and as a result elicited specific anti-preS2 antibodies and significantly higher titre of anti-HBs antibodies, together with IgG isotype profile indicating some Th1 polarisation, apart from the main Th2 response.AbstractHBV prevalence is still threatening, regardless of prevention programmes using vaccines containing S-HBsAg, supplemented by third-generation vaccines, comprising also M- and L-HBsAg. Plant expression systems offer a cost-effective production option of the antigens. Plant-derived S- and M-HBsAg, intramuscularly delivered to mice, elicited anti-HBs antibodies several times higher than high responsiveness threshold titre. M-HBsAg induced stronger response of anti-HBs and also specific anti-preS2 antibodies. IgG isotype profiles indicated mainly Th2 response, yet Th1 polarisation was also pointed out, in some larger extent for M-HBsAg. These results correspond to research on CHO-derived M-HBsAg vs. commercial vaccines based on S-HBsAg and support potency of plant-derived antigens as alternative injection vaccines.
Acta Physiologiae Plantarum | 2002
Tomasz Pniewski; Józef Kapusta; Andrzej B. Legocki
The complete protocols for long-term micropropagation of some cultivars of four lupin species: Lupinus luteus, L. albus, L. angustifolius and L. mutabilis were elaborated. The shoots were regenerated in vitro via induction of axillary buds development. Plantlets were multiplicated on lowered salts MS-derived media containing BAP in diverse and generally low concentrations. Significant differences in regeneration capacity between species and cultivars were observed. The highest multiplication ratio revealed L. mutabilis and L. luteus. Regenerated shoots were rooted in vitro on low-salts MS-derived media with B5 vitamins. Media were supplemented with different auxins that affected roots formation of particular species and cultivars. Rooting ability of regenerated shoots decreased rapidly through in vitro culture. For that reason, grafting was applied as an alternative method of transfer of shoots to in vivo conditions. This method turned out to be successful for the majority of studied species and cultivars. Complete rooted or grafted plantlets were cultivated in pots with perlit in greenhouse.
Acta Societatis Botanicorum Poloniae | 2014
Anna Mikuła; Maria Wesołowska; Józef Kapusta; Lutosława Skrzypczak; Jan J. Rybczyński
Archivum Immunologiae Et Therapiae Experimentalis | 2010
Józef Kapusta; Tomasz Pniewski; Jacek Wojciechowicz; Piotr Bociag; Andrzej Płucienniczak
Journal of Applied Genetics | 2005
Tomasz Pniewski; Józef Kapusta